Intramuscular injection in the breast muscle or subcutaneous injection in the neck area of the chicken on two occasions: at the age of 2-5 weeks
Producer :
DHN,CHINA
Packing :
250 ml bottles of 500 doses
Product Specifications
Indications for Use: For control and prevention of Highly Pathogenic Avian Influenza (HPAI) Contains two new epidemic H5 strains with broad protective capacity Induces appropriate immunity response against all influenza viruses with hemagglutinin H5 surface protein Provides 100% protection against H5N8 subtypes High quality and advanced manufacturing technology Vaccine Composition: Formulated with MARCOL 52 adjuvant, which stimulates nonspecific immunity and does not cause any local reaction at the injection site. Before inactivation, the HA titers of strains were: RE-6 ≥ 9 log₂ and RE-8 ≥ 8 log₂. Dosage and Administration: Intramuscular injection into the breast muscle or subcutaneous injection in the neck area. Chickens: Two doses – at 2–5 weeks of age: 0.3 ml; above 5 weeks of age: 0.5 ml Ducks: Two doses – at 2–5 weeks of age: 0.5 ml; above 5 weeks of age: 1 ml Geese: Two doses – at 2–5 weeks of age: 0.5 ml; above 5 weeks of age: 1.5 ml A minimum interval of 4 weeks should be maintained between the first and second doses. Storage Conditions: Store at 2–8 °C and keep awayfrom light. Avoid freeze. Shelf Life: 24 months from the date of production.
